Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Cryptosporidium is a major cause of diarrhea in children in developing countries. However, there is no vaccine available and little is known about immune responses to protective antigens. We investigated antibody responses to p23, a putative vaccine candidate, in children in Bangladesh with cryptosporidiosis and diarrhea (cases) and uninfected children with diarrhea (controls), and p23 gene polymorphisms in infecting species. Serum IgM, IgG, and IgA responses to p23 were significantly greater in cases than controls after three weeks of follow-up. Cases with acute diarrhea had significantly greater serum IgA and IgM responses than those with persistent diarrhea, which suggested an association with protection from prolonged disease. The p23 sequences were relatively conserved among infecting species and subtype families. Although most children were infected with Cryptosporidium hominis, there was a cross-reactive antibody response to C. parvum antigen. These results support further development of p23 as a vaccine candidate.

[1]  E. Naumova,et al.  Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh. , 2011, The American journal of tropical medicine and hygiene.

[2]  Melanie Mackay,et al.  Genetic Diversity of Cryptosporidium spp. from Bangladeshi Children , 2011, Journal of Clinical Microbiology.

[3]  G. Kang,et al.  Cryptosporidiosis in patients with HIV/AIDS , 2011, AIDS.

[4]  Heping Zhang,et al.  Immunogenicity of Orally Administrated Recombinant Lactobacillus casei Zhang Expressing Cryptosporidium parvum Surface Adhesion Protein P23 in Mice , 2011, Current Microbiology.

[5]  Jing Luo,et al.  Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection. , 2010, Vaccine.

[6]  A. White,et al.  Treatment of cryptosporidiosis: do we know what we think we know? , 2010, Current opinion in infectious diseases.

[7]  S. Collinet-Adler,et al.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  K. Liu,et al.  Divalent Cp15–23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection , 2010, Parasite immunology.

[9]  G. Kang,et al.  Multisite Study of Cryptosporidiosis in Children with Diarrhea in India , 2010, Journal of Clinical Microbiology.

[10]  C. Holland,et al.  Identification of a high diversity of Cryptosporidium species genotypes and subtypes in a pediatric population in Nigeria. , 2010, The American journal of tropical medicine and hygiene.

[11]  H. Ward,et al.  Human immune responses in cryptosporidiosis. , 2010, Future microbiology.

[12]  G. Kang,et al.  Polymorphic Mucin Antigens CpMuc4 and CpMuc5 Are Integral to Cryptosporidium parvum Infection In Vitro , 2009, Eukaryotic Cell.

[13]  J. Chai,et al.  Antibody responses to Cryptosporidium antigen in HIV-positive patients in the Republic of Korea. , 2008, The Korean journal of parasitology.

[14]  Gregory D. Sturbaum,et al.  Antigenic differences within the Cryptosporidium hominis and Cryptosporidium parvum surface proteins P23 and GP900 defined by monoclonal antibody reactivity. , 2008, Molecular and biochemical parasitology.

[15]  Jean-Michel Claverie,et al.  Phylogeny.fr: robust phylogenetic analysis for the non-specialist , 2008, Nucleic Acids Res..

[16]  W. Snelling,et al.  Cryptosporidiosis in developing countries. , 2007, Journal of infection in developing countries.

[17]  W. Secor,et al.  Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum , 2007, Parasitology Research.

[18]  P. Hunter,et al.  Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. , 2007, British journal of clinical pharmacology.

[19]  G. Craun,et al.  Serological responses to Cryptosporidium-specific antigens in Czech populations with different water sources , 2007, Epidemiology and Infection.

[20]  G. Kang,et al.  Molecular and Spatial Epidemiology of Cryptosporidiosis in Children in a Semiurban Community in South India , 2007, Journal of Clinical Microbiology.

[21]  A. Hubbard,et al.  The natural history of antibody responses to Cryptosporidium parasites in men at high risk of HIV infection. , 2006, The Journal of infectious diseases.

[22]  P. Wong,et al.  Molecular characterization of the Cryptosporidium cervine genotype , 2006, Parasitology.

[23]  J. Wanyiri,et al.  Molecular basis of Cryptosporidium-host cell interactions: recent advances and future prospects. , 2006, Future microbiology.

[24]  A. White,et al.  An updated review on Cryptosporidium and Giardia. , 2006, Gastroenterology clinics of North America.

[25]  R. Gilman,et al.  Longitudinal Analysis of Cryptosporidium Species-Specific Immunoglobulin G Antibody Responses in Peruvian Children , 2006, Clinical and Vaccine Immunology.

[26]  R. Gilman,et al.  Changes in Serum Immunoglobulin G Levels as a Marker for Cryptosporidium sp. Infection in Peruvian Children , 2005, Journal of Clinical Microbiology.

[27]  M. Sinclair,et al.  Protective immunity associated with a strong serological response to a Cryptosporidium-specific antigen group, in HIV-infected individuals. , 2005, The Journal of infectious diseases.

[28]  T. Yi,et al.  Expression of the recombinant fusion protein CP15-23 of Cryptosporidium parvum and its protective test. , 2005, Journal of nanoscience and nanotechnology.

[29]  Hiroshi Suzuki,et al.  Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and Evaluation of its Protective Effects , 2005, The Journal of parasitology.

[30]  G. Craun,et al.  How clean must our drinking water be: the importance of protective immunity. , 2005, The Journal of infectious diseases.

[31]  G. Craun,et al.  Serological responses to Cryptosporidium antigens among women using riverbank-filtered water, conventionally filtered surface water and groundwater in Hungary. , 2005, Journal of water and health.

[32]  M. Jenkins Present and future control of cryptosporidiosis in humans and animals , 2004, Expert review of vaccines.

[33]  Gregory A. Buck,et al.  The genome of Cryptosporidium hominis , 2004, Nature.

[34]  S. Calderwood,et al.  Cryptosporidiosis among Bangladeshi children with diarrhea: a prospective, matched, case-control study of clinical features, epidemiology and systemic antibody responses. , 2004, The American journal of tropical medicine and hygiene.

[35]  G. Craun,et al.  Analysis of serological responses to Cryptosporidium antigen among NHANES III participants. , 2004, Annals of epidemiology.

[36]  Ping Xu,et al.  Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum , 2004, Science.

[37]  E. Naumova,et al.  Serological evidence of Cryptosporidium infections in a Russian city and evaluation of risk factors for infections. , 2004, Annals of epidemiology.

[38]  Gregory D. Sturbaum,et al.  Nucleotide changes within three Cryptosporidium parvum surface protein encoding genes differentiate genotype I from genotype II isolates. , 2003, Molecular and biochemical parasitology.

[39]  Y. Takashima,et al.  RECOMBINANT BOVINE HERPESVIRUS-1 EXPRESSING p23 PROTEIN OF CRYPTOSPORIDIUM PARVUM INDUCES NEUTRALIZING ANTIBODIES IN RABBITS , 2003, The Journal of parasitology.

[40]  Melanie Mackay,et al.  Cryptosporidium species: new insights and old challenges. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  R. Guerrant,et al.  Cryptosporidiosis: epidemiology and impact. , 2002, Microbes and infection.

[42]  M. Riggs Recent advances in cryptosporidiosis: the immune response. , 2002, Microbes and infection.

[43]  L. Perryman,et al.  Efficacy of Monoclonal Antibodies against Defined Antigens for Passive Immunotherapy of Chronic Gastrointestinal Cryptosporidiosis , 2002, Antimicrobial Agents and Chemotherapy.

[44]  L. M. Smith,et al.  Human T and B Cell Immunoreactivity to a Recombinant 23-kDa Cryptosporidium parvum Antigen , 2001, The Journal of parasitology.

[45]  J. Priest,et al.  Enzyme Immunoassay Detection of Antigen-Specific Immunoglobulin G Antibodies in Longitudinal Serum Samples from Patients with Cryptosporidiosis , 2001, Clinical Diagnostic Laboratory Immunology.

[46]  C. Wyatt,et al.  EVIDENCE FOR THE EMERGENCE OF A TYPE-1–LIKE IMMUNE RESPONSE IN INTESTINAL MUCOSA OF CALVES RECOVERING FROM CRYPTOSPORIDIOSIS , 2001, The Journal of parasitology.

[47]  L. Perryman,et al.  Detection of Mucosally Delivered Antibody to Cryptosporidium parvum p23 in Infected Calves , 2000, Annals of the New York Academy of Sciences.

[48]  L. M. Smith,et al.  A 23-kDa recombinant antigen of Cryptosporidium parvum induces a cellular immune response on in vitro stimulated spleen and mesenteric lymph node cells from infected mice. , 2000, Experimental parasitology.

[49]  Deborah A Schaefer,et al.  Characterization and Formulation of Multiple Epitope-Specific Neutralizing Monoclonal Antibodies for Passive Immunization against Cryptosporidiosis , 2000, Infection and Immunity.

[50]  D. D. de Graaf,et al.  Speculation on whether a vaccine against cryptosporidiosis is a reality or fantasy , 1999, International Journal for Parasitology.

[51]  J. Priest,et al.  Detection by Enzyme Immunoassay of Serum Immunoglobulin G Antibodies That Recognize SpecificCryptosporidium parvum Antigens , 1999, Journal of Clinical Microbiology.

[52]  M. Jones,et al.  Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein. , 1999, Vaccine.

[53]  H. Dupont,et al.  The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. , 1998, The Journal of infectious diseases.

[54]  M. Riggs,et al.  Role of Immunoglobulin A Monoclonal Antibodies against P23 in Controlling Murine Cryptosporidium parvum Infection , 1998, Infection and Immunity.

[55]  R. Calderon,et al.  A two-year follow-up survey of antibody to Cryptosporidium in Jackson County, Oregon following an outbreak of waterborne disease , 1998, Epidemiology and Infection.

[56]  D. Jasmer,et al.  A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. , 1996, Molecular and biochemical parasitology.

[57]  C. Sterling,et al.  Immunofluorescent microscopical visualization of trails left by gliding Cryptosporidium parvum sporozoites. , 1991, The Journal of parasitology.

[58]  M. Arrowood,et al.  Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice , 1989, Infection and immunity.

[59]  Lihua Xiao Molecular epidemiology of cryptosporidiosis: an update. , 2010, Experimental parasitology.

[60]  Chen Zhao-guo Cloning and Sequence Comparison of P23 Gene of Different Cryptosporidium Genotypes , 2010 .

[61]  D. D. de Graaf,et al.  Screening of the T- and B-cell antigenicity in neonatal calves of the His-tagged Cryptosporidium parvum antigens CP15, CP15/60, P23 and TRAP-C1. , 2002, Folia parasitologica.

[62]  P. Lammie,et al.  Enzyme-linked immunoelectrotransfer blot analysis of a cryptosporidiosis outbreak on a United States Coast Guard cutter. , 1998, The American journal of tropical medicine and hygiene.